These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31884560)

  • 21. ASO Author Reflections: Assessing the Diagnostic Accuracy of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen to Detect Recurrent Colon Cancer.
    Dawood ZS; Moazzam Z; Pawlik TM
    Ann Surg Oncol; 2023 Jan; 30(1):275-276. PubMed ID: 36310308
    [No Abstract]   [Full Text] [Related]  

  • 22. C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management.
    Thirunavukarasu P; Sukumar S; Sathaiah M; Mahan M; Pragatheeshwar KD; Pingpank JF; Zeh H; Bartels CJ; Lee KK; Bartlett DL
    J Natl Cancer Inst; 2011 Apr; 103(8):689-97. PubMed ID: 21421861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen.
    Carpelan-Holmström MA; Haglund CH; Roberts PJ
    Dis Colon Rectum; 1996 Jul; 39(7):799-805. PubMed ID: 8674374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Univariate and multivariate regression analyses of recurrence and metastasis of colon cancer after radical resection].
    Ren JQ; Zhou ZW; Wan DS; Lu ZH; Chen G; Wang GQ; Tang SX; Wang JJ
    Ai Zheng; 2006 May; 25(5):591-5. PubMed ID: 16687080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-treatment surveillance in a large cohort of patients with colon cancer.
    Hu CY; Delclos GL; Chan W; Du XL
    Am J Manag Care; 2011 May; 17(5):329-36. PubMed ID: 21718080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.
    Osterman E; Glimelius B
    Dis Colon Rectum; 2018 Sep; 61(9):1016-1025. PubMed ID: 30086050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of chemotherapy benefit for colon cancers.
    Gilbert JA
    Lancet Oncol; 2016 Mar; 17(3):e91. PubMed ID: 26831289
    [No Abstract]   [Full Text] [Related]  

  • 28. Carcinoembryonic antigen in patients with breast or colon cancer.
    Lee YN
    West J Med; 1978 Nov; 129(5):374-80. PubMed ID: 364839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Stratification in Patients with Stage II Colon Cancer.
    Amri R; England J; Bordeianou LG; Berger DL
    Ann Surg Oncol; 2016 Nov; 23(12):3907-3914. PubMed ID: 27380640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of tumor marker NCC-ST 439 in large bowel cancers.
    Yamaguchi A; Kurosaka Y; Ishida T; Nishimura G; Kanno M; Kosaka T; Yonemura Y; Miyazaki I
    Dis Colon Rectum; 1991 Oct; 34(10):921-4. PubMed ID: 1914727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of allogeneic blood transfusion in patients with stage II colon cancer.
    Meng J; Lu XB; Tang YX; Sun GP; Li X; Yan YF; Liang GF; Ma SP; Li XX
    Asian Pac J Cancer Prev; 2013; 14(1):347-50. PubMed ID: 23534751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance.
    Hall MJ; Morris AM; Sun W
    Am Soc Clin Oncol Educ Book; 2018 May; 38():220-230. PubMed ID: 30231337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic criteria and risk groups in colorectal cancer].
    Mentges B; Brückner R
    Wien Med Wochenschr; 1988 Jul; 138(13):317-22. PubMed ID: 3188544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapse of colon cancer followed by polymyositis: report of a case and review of the literature.
    Nyui S; Osanai H; Ohba S; Masuoka H; Yoshida Y
    Surg Today; 1997; 27(6):559-62. PubMed ID: 9306552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification.
    Radespiel-Tröger M; Hohenberger W; Reingruber B
    Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma.
    van der Schouw YT; Verbeek AL; Wobbes T; Segers MF; Thomas CM
    Br J Cancer; 1992 Jul; 66(1):148-54. PubMed ID: 1379057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of serum tumor markers in the management of patients with malignancy.
    Markman M
    J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
    [No Abstract]   [Full Text] [Related]  

  • 38. ASO Author Reflections: Comparison of Prognostic Impact of Various Systemic Inflammatory Markers for Stage II/III Colon Cancer.
    Suzuki S; Akiyoshi T
    Ann Surg Oncol; 2020 Mar; 27(3):853-854. PubMed ID: 31720932
    [No Abstract]   [Full Text] [Related]  

  • 39. Loco-regional recurrence from colon cancer: a population-based study.
    Sjövall A; Granath F; Cedermark B; Glimelius B; Holm T
    Ann Surg Oncol; 2007 Feb; 14(2):432-40. PubMed ID: 17139459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between serum ELAM-1 and metastasis among patients with colon cancer.
    Takahashi Y; Mai M; Watanabe M; Tokiwa M; Nishioka K
    Dis Colon Rectum; 1998 Jun; 41(6):770-4. PubMed ID: 9645747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.